| Louis Sonstegard, MD | |
|
701 Dellwood St S, Cambridge, MN 55008-1920 | |
| (763) 689-7700 | |
| (763) 689-7941 |
| Full Name | Louis Sonstegard |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 52 Years |
| Location | 701 Dellwood St S, Cambridge, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427010214 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 20826 (Minnesota) | Primary |
| 207Q00000X | Family Medicine | 20826 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hidalgo Medical Services | 4587572250 | 29 |
News Archive
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Chlorothiazide Sodium for Injection, USP. APP expects to launch Chlorothiazide Sodium for Injection, USP in the fourth quarter of 2009.
A multidisciplinary team from the University of Toronto, with experts from the Faculty of Dentistry and the Waakebiness-Bryce Institute for Indigenous Health at the Dalla Lana School of Public Health have been awarded a five year, $1.5 million grant from the Canadian Institutes of Health Research to study the impact of cannabis use on the oral health of Indigenous populations.
In the year following a heart attack, financial barriers to healthcare are linked to worse health outcomes in young women and young men, according to a new study by Yale School of Medicine researchers published in the current issue of the Journal of the American Heart Association.
Type 2 diabetes is a major contributor to mortality in patients with bipolar disorder who are admitted to general hospitals, a study shows.
By blocking the cellular signaling activity of a protein, a team of neuroscientists at Cold Spring Harbor Laboratory (CSHL) has prevented memory loss in fruit flies caused by brain plaques similar to those thought to cause Alzheimer's disease in humans. The study also resolves a long-standing controversy about the role of this protein, PI3 kinase, which was previously thought to have a protective function against the disease.
› Verified 2 days ago
| Entity Name | Hidalgo Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306843180 PECOS PAC ID: 4587572250 Enrollment ID: O20040303001246 |
News Archive
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Chlorothiazide Sodium for Injection, USP. APP expects to launch Chlorothiazide Sodium for Injection, USP in the fourth quarter of 2009.
A multidisciplinary team from the University of Toronto, with experts from the Faculty of Dentistry and the Waakebiness-Bryce Institute for Indigenous Health at the Dalla Lana School of Public Health have been awarded a five year, $1.5 million grant from the Canadian Institutes of Health Research to study the impact of cannabis use on the oral health of Indigenous populations.
In the year following a heart attack, financial barriers to healthcare are linked to worse health outcomes in young women and young men, according to a new study by Yale School of Medicine researchers published in the current issue of the Journal of the American Heart Association.
Type 2 diabetes is a major contributor to mortality in patients with bipolar disorder who are admitted to general hospitals, a study shows.
By blocking the cellular signaling activity of a protein, a team of neuroscientists at Cold Spring Harbor Laboratory (CSHL) has prevented memory loss in fruit flies caused by brain plaques similar to those thought to cause Alzheimer's disease in humans. The study also resolves a long-standing controversy about the role of this protein, PI3 kinase, which was previously thought to have a protective function against the disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Louis Sonstegard, MD Po Box 43, Mr 10809, Minneapolis, MN 55440-0043 Ph: (612) 262-4813 | Louis Sonstegard, MD 701 Dellwood St S, Cambridge, MN 55008-1920 Ph: (763) 689-7700 |
News Archive
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Chlorothiazide Sodium for Injection, USP. APP expects to launch Chlorothiazide Sodium for Injection, USP in the fourth quarter of 2009.
A multidisciplinary team from the University of Toronto, with experts from the Faculty of Dentistry and the Waakebiness-Bryce Institute for Indigenous Health at the Dalla Lana School of Public Health have been awarded a five year, $1.5 million grant from the Canadian Institutes of Health Research to study the impact of cannabis use on the oral health of Indigenous populations.
In the year following a heart attack, financial barriers to healthcare are linked to worse health outcomes in young women and young men, according to a new study by Yale School of Medicine researchers published in the current issue of the Journal of the American Heart Association.
Type 2 diabetes is a major contributor to mortality in patients with bipolar disorder who are admitted to general hospitals, a study shows.
By blocking the cellular signaling activity of a protein, a team of neuroscientists at Cold Spring Harbor Laboratory (CSHL) has prevented memory loss in fruit flies caused by brain plaques similar to those thought to cause Alzheimer's disease in humans. The study also resolves a long-standing controversy about the role of this protein, PI3 kinase, which was previously thought to have a protective function against the disease.
› Verified 2 days ago
Dr. Dawn A Schreifels, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 763-689-7700 | |
Michael J. Joyce, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Dellwood St S, Cmc, Cambridge, MN 55008 Phone: 763-689-7700 | |
Debra S Larson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 763-689-7700 Fax: 763-689-7941 | |
Allen J Mork, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 763-689-7700 | |
Robert P Callen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 763-689-7700 Fax: 763-689-7941 | |
Daniel Charles Wallace, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 763-689-7700 | |
Charles J Phillips, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Dellwood St S, Cambridge, MN 55008 Phone: 763-689-7700 Fax: 763-689-7941 |